Farallon Capital Management Llc: Recent Investment Activity Analysis

Farallon Capital Management Llc appears to be actively managing its portfolio during the period leading up to June 30, 2026. Based on available data, their activities this quarter show a clear preference for certain sectors and specific investment moves.

The investor's filing indicates several notable purchases:

• Electronic Arts Inc (EA) saw its share count increase by 100% during this period, suggesting a significant new investment or position build-up.
• Farallon Capital Management Llc's holdings in BridgEBio Pharma Inc (BBIO) remained unchanged, maintaining its 4.68% allocation.
• Protagonist Therapeutics Inc (PTGX)'s position stayed constant at 4.56%, showing no change in shares held by Farallon during this quarter.
• There was a substantial purchase of ImmunoVant Inc (IMVT), with share count jumping by an impressive 275.49%, adding significantly to the portfolio's allocation from 0.0% to 1.31%.
• The investor also increased its stake in Tango Therapeutics Inc (TNGX) by approximately 35%, raising the portfolio percentage allocation from an unknown prior level to 2.25%.
• Boston Scientific Corp (BSX)'s position grew by nearly 41%, boosting its allocation in Farallon's portfolio from a previous figure to 2.63%.
• Furthermore, Acadia Healthcare Company Inc (ACHC) experienced a large increase of about 143%, adding this stock with an allocation of 0.73% to the portfolio.

In contrast, Farallon also divested from certain positions during this quarter:

• The investor sold shares in Microsoft Corp (MSFT), which experienced a significant decrease of -52.54% in its position, reducing the allocation to 2.43%.
• Amazon Com Inc (AMZN) was another stock where Farallon reduced its stake substantially (-37.58%), lowering its portfolio percentage from a higher prior value down to 3.67%.

The overall holdings count for Farallon Capital Management Llc stands at 67 stocks as of the reporting date, reflecting an active management approach with frequent adjustments (indicated by position_change_count:59). The portfolio's sector allocation remains dominated by Healthcare, which accounts for approximately 66.69% of the total value.

Key observations from this quarter's filing include:

• The investor demonstrated a strong inclination towards Healthcare companies, evidenced by both new purchases and maintaining existing positions.
• Electronic Arts Inc (EA), Tango Therapeutics Inc (TNGX), ImmunoVant Inc (IMVT), and Acadia Healthcare Company Inc (ACHC) were among the most significant additions to their portfolio.
• Microsoft Corp and Amazon Com Inc represented notable exits from Farallon's investment strategy during this period.